Open Access
CC BY 4.0 · Journal of Health and Allied Sciences NU 2024; 14(02): 224-229
DOI: 10.1055/s-0043-1769582
Original Article

A Study on Enumeration of Factors Prone to the Development of COVID-19-Associated Mucormycosis

Authors

  • Sivakumar Velusamy

    1   Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, Tamil Nadu, India
  • Jayakumar Rajagopal

    2   Department of Respiratory Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India
  • Jessica Jayakumar

    1   Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, Tamil Nadu, India
  • Dharshini Parthiban

    1   Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, Tamil Nadu, India
  • Adeeb Ismail Zahir Hussain

    1   Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, Tamil Nadu, India

Author's Financial Disclosures None.
Preview

Abstract

Background Patients with pre-existing chronic medical conditions with altered immunity are prone to COVID-19-associated mucormycosis (CAM).

Objective In this study, our objectives were to identify the risk factors that increase the chances of developing CAM and to determine the severity of the risk factors of CAM. Thereby, we can optimize the modifiable risk factors for developing CAM in coronavirus disease 2019 (COVID-19) patients. For instance, better control of blood glucose levels in COVID-19 patients can decrease the risk of developing CAM.

Materials and Methods The data was collected retrospectively from 1000 COVID-19 infected patients, above the age of 18 years during the time period of March 2021 to August 2021, in which 86 patients had confirmed CAM.

Statistical Analysis Binary logistic regression and curve estimation analysis were performed using SPSS software version 29 for identifying the associated risk factors of CAM with the significance of p-value less than 0.05.

Results Factors such as severe inflammation (p = 0.048), high dose of steroid administration (p = 0.005), increasing age (p < 0.001), and prolonged hospital stay (p < 0.001) were statistically proven to be significant risk factors, associated with CAM.

Conclusion Increasing age, severe inflammation, high dose of steroid administration, and prolonged hospital stay have association with occurrence of CAM.

Ethics

The study obtained the human ethics permission from the Institutional Human Ethical Committee. The approval date and number are August 16, 2022 and IHEC # 208, respectively. Due to the retrospective study design, waiver of the informed consent was obtained.


Declaration

The study was performed in accordance with Declaration of Helsinki.




Publikationsverlauf

Artikel online veröffentlicht:
19. Juni 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India